Digital rectal examination

Show results for

Unknown (209)
Transcriptomics (21)
Genomics (16)
Clinical (6)
Genomic (3)
Metabolomics (2)
Proteomics (2)

Organisms

Homo sapiens (15)
Mus musculus (7)
Saccharomyces cerevisiae (2)
Andropogon gerardi (2)
Bacteria (2)
Canis lupus familiaris (2)
Cnidaria (2)
Cricetulus griseus (2)
Eukaryota (2)
Fasciola (2)
Hepatitis B virus (2)
Human betaherpesvirus 5 (2)
Madurella mycetomatis (2)
Mesocricetus auratus (2)
Miscanthus x giganteus (2)
Mus musculus (2)
Mycobacterium tuberculosis (2)
Orthoflavivirus (2)
Panicum virgatum (2)
Platyhelminthes (2)
Pseudomonas aeruginosa AES-1R (2)
Lupinus albus (1)
Trypanosoma brucei brucei (1)
Medicago sativa (1)
Zea mays (1)
Schizosaccharomyces pombe (1)
Salmonella enterica subsp. enterica serovar Typhimurium (1)
Drosophila melanogaster (1)
Arabidopsis thaliana (1)
synthetic construct (1)

Organisms

Homo sapiens (4)

Repository

biostudies-arrayexpress (29)
ENA (5)
dbGaP (3)
EGA (2)
MetaboLights (2)
pride (2)
geo (1)

Tissue

Urine (2)

Disease

Schizophrenia (1)
High-grade dysplasia (1)
Lymphatic drainage of the splenic flexure (1)
Low rectal cancer (1)
Inflammatory Bowel Diseases (1)
Colorectal cancer (1)
Rectal Neoplasms (1)
Colorectal Neoplasms (1)
Prostate adenocarcinoma (1)

Technology Type

Mass spectrometry (2)
Mass Spectrometry (2)
Gel-based experiment (1)
SWATH MS (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (2)
Maxwell® RSC 48 Instrument (Promega, AS8500) (1)
Transrectal ultrasound-guided systematic sampling of prostate tissue (TRUS biopsy) (1)
NextSeq 2000 (1)
NextSeq 550 (1)
Illumina NovaSeq 6000 (1)
NextSeq 500 (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2013 (13)
2023 (3)
2025 (2)
2015 (2)
2014 (2)
2012 (2)
2011 (2)
2010 (2)
2024 (1)
2021 (1)
2016 (1)
2009 (1)
2008 (1)
2022 (1)

CHEBI ID

CHEBI:16709 (2)
CHEBI:9300 (2)
CHEBI:4178 (2)
CHEBI:15741 (2)
CHEBI:545959 (2)
CHEBI:7916 (2)
CHEBI:17859 (2)
CHEBI:18183 (2)
CHEBI:18300 (2)
CHEBI:16411 (2)
CHEBI:30769 (2)
CHEBI:195171 (1)
CHEBI:2653 (1)
CHEBI:17576 (1)
CHEBI:182625 (1)
CHEBI:185950 (1)
CHEBI:176874 (1)
CHEBI:80532 (1)
CHEBI:62416 (1)
CHEBI:132423 (1)
CHEBI:79076 (1)
CHEBI:67205 (1)
CHEBI:16067 (1)
CHEBI:27427 (1)
CHEBI:32802 (1)
CHEBI:10086 (1)
CHEBI:31543 (1)
CHEBI:32303 (1)
CHEBI:2760 (1)
CHEBI:51312 (1)

Metabolite Name

Homovanillic acid (2)
Maleic acid (2)
Pantothenic acid (2)
Suberic acid (2)
Glutaric acid (2)
Anhalamine (1)
Antiarol (1)
4-Chloro-17alpha-methyl-17beta-hydroxy-4-androsten-3-one (1)
Coleonol (1)
Erythro-3-Hydroxy-Ls-aspartate (1)
Hydroxyindole (1)
Ribavirin (1)
5-Hydroxyindolepyruvate (1)
N5-(L-1-Carboxyethyl)-L-ornithine (1)
5-Oxo-1,2-campholide (1)
O-Hydroxylaminobenzoate (1)
N,N-Dimethyl-1,4-phenylenediamine (1)
(R)-3-Ureidoisobutyrate (1)
3-Amino-4-hydroxybenzoate (1)
Bupropion (1)
(S)-Piperidine-2-carboxamide (1)
3-Indoleacrylate (1)
2,4-Dinitrotoluene (1)
Diethylphosphoric acid (1)
Azacitidine (1)
5-Hydroxypyrazinamide (1)
3-Methyl-L-tyrosine (1)
3-(3,4-Dihydroxyphenyl)pyruvate (1)
Indoleglycerol phosphate (1)
5-Oxoavermectin ''1b'' aglycone (1)

First Public Date

2014 (4)
2024 (1)

Study status

Completed (3)
Recruiting (2)
Not yet recruiting (1)

Study type

RNA-seq of coding RNA (10)
Transcription profiling by array (7)
ChIP-seq (4)
Methylation profiling by high throughput sequencing (3)
Interventional (3)
Observational (2)
Unknown experiment type (1)
Cell line - One-color microarray (1)
DNA-seq (1)
RNA-seq of total RNA (1)
RNA-seq of non coding RNA (1)
Other (1)

Release Date

2022 (29)
2021 (28)
2023 (21)
2025 (20)
2013 (17)
2017 (17)
2024 (16)
2019 (15)
2015 (14)
2016 (13)
2020 (12)
2014 (9)
2018 (7)
2012 (5)
2009 (4)
2011 (3)
2026 (3)
2010 (2)
2008 (1)
2007 (1)
2003 (1)

Lab affiliation

Department of Medical Sciences, Institute of Biomedicine-iBiMED,Univerity of Aveiro, 3810-193 Aveiro,Portugal (1)
Johns Hopkins University (1)

Location

United Kingdom (2)
Egypt (1)
China (1)
Australia (1)
France (1)

Keyword

Examination (1)
Rectal examination (1)
Digital (1)
Endoscopy (1)
Primary care (1)
Sympomatic patients (1)
Point of care (1)
Digital Rectal examination (1)
Faecal Immunochemical Testing (1)

Previous page
1 / 26
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 26
Next page

Sort by:

Relevance

Page size

Microarray profiling of rectal tumor samples

Using Human WG CodeLink microarrays, we established the expression profiling of 26 LARC without metastasis to gain insight into the molecular signatures associated with response to treatment after CRT. The study initially included a total of 35 consecutive patients with locally advanced rectal cance...

ORGANISM(S): Homo sapiens

2014-01-03 | E-GEOD-53781 | biostudies-arrayexpress

Differentially Expressed Glycoproteins in Pre- and Post-Digital Rectal Examination Urine Samples for Detecting Aggressive Prostate Cancer

Nonaggressive prostate cancer (NAG-PCa) with Gleason score of 6 is considered as a low-risk disease and does not require clinical interventions. However, current assessment of aggressiveness of PCa is invasive using needle biopsies. Urine is an appealing biospecimen for noninvasive detection of aggr...

ORGANISM(S): Homo sapiens (Human)

2023-07-20 | PXD036468 | Pride

Informativeness to Digital Rectal Examination

Digital rectal examination is an act clinically performed daily by physicians and surgeons. It remains the key diagnostic test and directs the therapeutic management of cancer of the lower and middle rectum. It can be done in two main positions: lateral decubitus, and supine. However, no randomized ...

2135151 | ecrin-mdr-crc

Hydrogen peroxide irrigation as an adjunct to digital rectal examination for detection of penetrating low rectal injuries.

Not available

S-EPMC11337667 | biostudies-literature

Use of Digital Rectal Examination as an Adjunct to Prostate Specific Antigen in the Detection of Clinically Significant Prostate Cancer.

Not available

S-EPMC6719551 | biostudies-literature

Two-finger digital rectal examination for the diagnosis of anal fistula: protocol for a randomized controlled trial.

Not available

S-EPMC10331745 | biostudies-literature

Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone: Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above.

Not available